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Abstract: 49	
Sarcocystis fayeri is a canine protozoan parasite with an equine intermediate host. 50	
Historically classified as an incidental pathogen, recent literature has described the 51	
toxic effects of Sarcocystis fayeri in human food poisoning, and highlighted potential 52	
involvement in equine neuromuscular disease. Until now, horses were believed to be 53	
the exclusive intermediate host. This study reports the first molecular confirmation of 54	
S. fayeri in a donkey, and gives rise to the consideration of donkeys being a potential 55	
reservoir for the parasite. This finding is of particular importance in understanding the 56	
epidemiology of this disease. 57	
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1. Introduction 61	
The protozoan parasite Sarcocystis fayeri was first described in the United States 62	
following post-mortem identification in horses at slaughter (Dubey et al., 1977). 63	
These naturally infected horses were used to experimentally demonstrate the 64	
parasite’s intermediate equine ‘prey host’ and final canine ‘predator host’ life-cycle, 65	
that is typical of the genus. Bradyzoite infected equine tissue was fed to naïve 66	
domestic dogs which produced sporocysts in their faeces from twelve days following 67	
ingestion of infected meat (Dubey et al., 1977). The canine hosts remained free of 68	
clinical signs throughout the study. Sporocysts obtained from experimentally infected 69	
dogs were subsequently used to inoculate naïve ponies, with schizonts observed 70	
histologically in cardiac capillaries from ten days post-inoculation. Intramuscular 71	
cysts in the tongue, oesophagus, diaphragm and skeletal muscle of the ponies were 72	
noted from 50 days post-inoculation, and these cysts were infective to naïve canine 73	
hosts from day 77 (Fayer and Dubey, 1982). 74	
Pyrexia and mild anaemia were documented in the infected ponies of these 75	
experimental studies (Fayer and Dubey, 1982). Other authors studying naturally 76	
infected animals also described signs of muscular weakness, ataxia and weight loss 77	
(Cawthorn et al., 1990). Granulomatous and eosinophilic myositis has been 78	
documented histologically in cases where the pathogen has been confirmed by nested 79	
polymerase chain reaction (PCR) (Herd et al., 2015). Despite these descriptions of 80	
clinical disease, Sarcocystis fayeri has largely been considered an incidental finding 81	
in equids (Valentine, 2008). However, a recent study of sarcocyst involvement in the 82	
skeletal muscle of horses with neuromuscular disease has suggested that it may not be 83	
incidental in all cases. In this study, DNA was extracted from muscle samples of 15 84	
horses showing signs of neuromuscular disease and in which encysted sarcocysts had 85	
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been detected in muscle biopsies. Following nested PCR, sequence analysis 86	
demonstrated S. fayeri in six of these 15 samples, suggesting that this species may be 87	
of greater pathogenic significance than previously thought (Aleman et al., 2016).  88	
Pathogenic potential for humans has also been highlighted in Japan recently, where 89	
reports of food poisoning from the consumption of horsemeat has lead to the issue of 90	
public notifications regarding the safe preparation of raw horsemeat for human 91	
consumption (Harada et al., 2013). Further research has indicated a protein fraction of 92	
S. fayeri sarcocysts as a causal toxic agent (Kamata et al., 2014).  93	
Sarcocystis spp. infection within horses has a reported histological prevalence of up to 94	
93 % in some areas (Fukuyo et al., 2002). Sarcosporidiosis has also been reported in 95	
mules and donkeys (Kirmse, 1986) but this has been attributed to S. bertrami (S. 96	
equicanis), with S. fayeri undocumented in any equid other than the horse (Dubey et 97	
al., 2016). Here the authors report the first identification of S. fayeri in a donkey, 98	
which may have implications for epidemiology of disease. 99	
2. Study methodology and results 100	
As part of a study into haemoparasitic disease prevalence, 114 horse and donkey 101	
blood samples were collected from equids in villages in the Central River District of 102	
The Gambia between 2012 and 2013. Ethical approval for this study was granted by 103	
the University of Glasgow Ethics Committee.  104	
Blood samples were taken by jugular venipuncture into EDTA tubes and these were 105	
frozen at -20 °C, heat treated at 56 °C for 30 minutes for UK importation and then 106	
frozen at -20 °C until DNA extraction. Each sample had a dedicated form recording 107	
the animal’s packed cell volume, total plasma protein concentration and the findings 108	
of a detailed clinical examination and body condition score (Carrol and Huntington, 109	
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1988) as assessed by an experienced veterinary surgeon (AGR). The presence of 110	
neurological signs or other concurrent debilitating disease led to the exclusion of the 111	
animal from the study due to avoid any confounding effect on outcome. 112	
The samples were screened for piroplasmosis by nested PCR with a modified 113	
Babesia/Theileria 18S SSU rRNA catch-all primer set (Criado-Fornelio et al., 2003). 114	
Reaction conditions were an initial denaturation at 94 °C for 5 minutes, followed by 115	
30 cycles of 94 °C for 45s, annealing at 67°C (external primers) or 57 °C (internal 116	
primers) for 60s, elongation at 72 °C for 60s, with a final extension at 72 °C for 5 117	
minutes. A 1:10 dilution of the primary reaction product was used as a template for 118	
the secondary reaction. 119	
One sample, ‘Gam56’, produced a larger PCR product (~400 bp) than expected for 120	
Babesia or Theileria genera parasites (~385 bp). The PCR product was purified 121	
(QIAquick PCR purification kit, Qiagen®) and sent for sequencing (Eurofins 122	
Genomics®, Germany). Following BLAST analysis, the nucleotide sequence was 123	
found to have a high level of identity (up to 97 %) with Sarcocystis fayeri 18S SSU 124	
rRNA gene sequences deposited in the non-redundant NCBI database. 125	
To investigate this finding, and assess for Sarcocystis presence in cohort animals, 126	
Gam56 and 20 other donkey blood samples taken from the same village were 127	
subjected to a Sarcocystis 18S-specific nested PCR utilising previously published 128	
primers, S5/ S4 (external) and S7/S2 (internal) (Fischer and Odening, 1998), and 129	
reaction conditions (Aleman et al., 2016). Again, Gam56 generated an amplicon, 130	
which following direct sequencing, displayed a high level of identity to the S. fayeri 131	
sequences in the NCBI database (up to 97%). All other tested samples did not 132	
generate a detectable amplicon. 133	
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The target areas of the ‘catch-all’ and Sarcocystis-specific nested reactions 134	
overlapped. Using the forward and reverse sequences representing the amplicons from 135	
both primer sets, a consensus sequence was generated and submitted to GenBank™, 136	
under the accession number KY039162. A phylogenetic tree was generated using this 137	
consensus sequence together with sequences from sets of species closely related to 138	
and including S. fayeri, namely S. neurona, S. hominis and S. cruzi; a Babesia caballi 139	
sequence was included as an outlier in order to root the tree. An alignment was 140	
generated using MUSCLE (Edgar, 2004) and a boot-strapped phylogenetic tree 141	
constructed with MEGA7 (Kumar et al., 2016), using a neighbour-joining method. A 142	
neighbour-joining tree was deemed more suitable than a maximum-likelihood tree 143	
due to the presence of indel areas within the nucleotide alignment. The tree was 144	
visualised within MEGA7 and is illustrated in Figure 1, along with the relevant 145	
GenBank™ accession numbers. The novel sequence derived from the donkey was 146	
clearly placed within the clade representing S. fayeri. An alignment of the Gam56 147	
consensus with the three closest identified GenBankTM sequences is shown in 148	
supplementary data. 149	
The samples were also screened for trypanosomosis by PCR using previously 150	
described primers (Masiga et al., 1992). Gam56 was found to be PCR positive for 151	
Trypanosoma congolense only. The clinical examination and blood analysis findings 152	
are summerised in Table 1. Using PCR primers specific for the donkey ND2 gene 153	
(Kesmen et al., 2007), the animal that provided the Gam56 sample was verified as 154	
being a donkey. This donkey was re-sampled weekly for two weeks after the initial 155	
sampling. The samples were subjected to the same Sarcocystis-specific nested PCR, 156	
which proved negative (Table 1). 157	
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3. Conclusion 158	
Sarcocystis fayeri is gaining recent interest as both a pathogen of horses and as an 159	
inducer of toxic food poisoning. 160	
The animal identified in this report demonstrated anaemia (reduced packed cell 161	
volume and pale mucous membranes), depression, intermittent pyrexia and increased 162	
pulse and respiration rate (likely secondary to the anaemia and pyrexia). There was an 163	
increase in plasma total protein, although probably due to an inflammatory response 164	
following the trypanocidal treatment. These are common clinical signs of 165	
trypanosomosis, so due to the co-infection with T. congolense, the clinical 166	
significance of the S. fayeri infection could not be determined. Also, the potential 167	
association of S. fayeri and neuromuscular disease suggested by other authors 168	
(Aleman et al., 2016) was not evident in this case, although follow-up only took place 169	
over a two-week period. 170	
The discovery of Sarcocystis-DNA in a blood sample is unusual considering the 171	
typical cyst location for these parasites within tissues, principally muscle of 172	
chronically infected hosts. One hypothesis to explain the results is that the detected 173	
DNA was derived from merozoites during their haematogenous dissemination 174	
following endodyogeny in endothelial cells of blood vessels. This blood-borne stage 175	
has been observed in other Sarcocystis spp. and utilised for experimental infection via 176	
blood transfusion (Fayer and Leek, 1979) and its transient nature may explain the 177	
negative findings in subsequent weeks. 178	
Another hypothesis, although less likely, is that during sampling the needle passed 179	
through a schizont in the endothelium of the jugular vein (Dubey et al., 2001), thus 180	
contaminating the sample with sufficient DNA to detect at PCR. This theory would 181	
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also be in keeping with the later negative results, as the sample would have been 182	
taken from a different part of the jugular. 183	
In the instance of this case, it was not possible to confirm cyst formation within the 184	
subject. However, with presence of circulating parasite DNA it is not unreasonable to 185	
assume their establishment, raising the possibility of the donkey as an intermediate 186	
host. 187	
The subject also received a treatment of diminazene diaceturate (3.5 mg/kg i.m.) at 188	
week 1. While this drug is known for its activity against piroplasmosis and 189	
trypanosomosis (Peregrin and Mamman, 1993), it is not a recognised treatment for 190	
sarcosporidiosis in equines (Dubey et al., 2001). Therefore, it is considered unlikely 191	
that this treatment is related to the subsequent negative results. 192	
The confirmation of S. fayeri in a donkey host has not been previously reported. The 193	
NCBI database currently contains 15 reference sequences annotated as S. fayeri. 194	
Whilst there is a relatively large degree of polymorphism between these sequences, 195	
the isolate sequenced within this study falls firmly within the S. fayeri clade. 196	
This finding raises the possibility of the donkey acting as an alternative reservoir for 197	
the parasite. Such a scenario may be of particular importance given the huge size of 198	
the working donkey population present in many areas of the world. In light of recent 199	
work into the possible under-diagnosis of S. fayeri disease in both equine (Aleman et 200	
al., 2016) and human health (Harada et al., 2013), the potential role of the donkey in 201	
the epidemiology of this parasite should not be over-looked.  202	
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Table 1. Clinical and diagnostic data pertaining to sample ‘Gam56’ described in this study. Units of measurement and reference ranges are 
shown in parentheses where applicable. 
Identity Estimated Age Sex Estimated Weight  
Gam56 6 years Male 135kg 
    
 Week 1 Week 2 Week 3 
Attitude Dull Bright Bright 
Temperature (36.2 – 37.8°C) 38.2°C 39.1°C 37.6°C 
Pulse Rate (beats per minute) (40-53) 72 80 72 
Respiratory Rate (breaths per minute) (18-24) 64 40 24 
Mucous Membranes Pale Pale Pale 
Body Condition Score (1-5)  2.5 2 2 
Packed Cell Volume (%) (≥24) 12 26 27 
Total Protein (g/L) (60-80) 74 94 90 
Treatment Given Diminazene diaceturate None None 
T. congolense PCR + + + 
T. vivax PCR - - - 
T. brucei PCR - - - 
Babesia/Theileria PCR + (larger size amplicon) - - 
Sarcocystis PCR + - - 
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Figure 1.  A neighbour-joining tree inferring the evolutionary relationship of the 18S 
SSU rRNA gene fragment from the Sarcocystis fayeri sample (KY039162) described 
in this study. Included are all current comparable S. fayeri sequences available 
through GenBankTM, and representative sequences of S. neurona, S. cruzi, S. hominis, 
and B. caballi (to which the tree is rooted) with accession numbers noted. Bootstrap 
values >70 % are shown, as generated from 1,000 replications. Up to 95 % alignment 
gaps were allowed at any position (5 % site coverage). The tree is drawn to scale, 
with branch lengths in the same units as those of the evolutionary distances used to 
infer the phylogenetic tree (sum of branch lengths = 0.53). The evolutionary distances 
were computed using the Jukes-Cantor method and are in the units of the number of 
base substitutions per site. The tree was created using the MEGA7 package (Kumar et 
al., 2016). The GenBank™ accession numbers are included. 
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Supplementary Figure 1. An alignment of the Gam56 consensus (KY039162) with the 
three top-scoring BLAST ‘hits’ from the GenBankTM database. The alignment was 
performed with MUSCLE 3.8 (Edgar, 2004). 
 
